DBJClass II
Antiparietal Antibody, Indirect Immunofluorescent, Antigen, Control
21 CFR 866.5110 / Immunology
DBJ is the FDA product code for Antiparietal Antibody, Indirect Immunofluorescent, Antigen, Control, a class II device type, regulated under 21 CFR 866.5110. As of , FDA records hold 2 510(k) clearances under this code, the most recent dated , and no recalls.
Classification record
- Product code
- DBJ
- Device name
- Antiparietal Antibody, Indirect Immunofluorescent, Antigen, Control
- Regulation
- 21 CFR 866.5110
- Device class
- Class II
- Review panel
- Immunology
- Submission type
- 510(k)
- Implant
- No
- Life sustaining or supporting
- No
- GMP exempt
- No
- Third party review eligible
- Yes
- Ingested clearances
- 2
- Ingested recalls
- 0
Clearances, product code DBJ
By decision yearShow the numbers
| Year | Clearances |
|---|---|
| 1979 | 1 |
| 1993 | 1 |
Applicants with the most clearances
Product code DBJ| Applicant | Clearances |
|---|---|
| Elias U.S.A., Inc. | 1 |
| Medica Corp. | 1 |
Companies listing this code with FDA
Companies whose registered establishments list this codeFIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
